is supported by NIH/NCI Cancer Center Support Grant (P30 CA008748) and the Searle Scholars Program
Consent for publication All ethical principles are considered in this article
However, be especially careful when using children and the elderly
Key Takeaways Methylene blue, first synthesized in 1876, is a versatile compound with significant medical applications, including treating methemoglobinemia, neuroprotection, and as an antimalarial agent
Unfortunately, the spike protein has been shown to deplete glutathione levels, making it harder for the body to keep inflammation in check and recover efficiently
Stop and Seek Help If Any signs of allergic reactionhives, swelling, breathing difficulty (stop immediately, seek help) Severe or persistent headaches that don't respond to dose reduction Excessive daytime drowsiness affecting your ability to function Unusual mood changes or psychological symptoms You've completed your planned cycle (typically 4-6 weeks) Your healthcare provider recommends discontinuation DSIP is a research peptide, not an FDA-approved medication
